{"id":"https://openalex.org/W2790164541","doi":"https://doi.org/10.1158/1538-7445.sabcs17-pd7-01","title":"Abstract PD7-01: Impact of guideline concordant treatment on cost and health care utilization in early stage breast cancer patients","display_name":"Abstract PD7-01: Impact of guideline concordant treatment on cost and health care utilization in early stage breast cancer patients","publication_year":2018,"publication_date":"2018-02-15","ids":{"openalex":"https://openalex.org/W2790164541","doi":"https://doi.org/10.1158/1538-7445.sabcs17-pd7-01","mag":"2790164541"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs17-pd7-01","doi":"https://doi.org/10.1158/1538-7445.sabcs17-pd7-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs17-pd7-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100873841","display_name":"CP Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"CP Williams","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855","https://openalex.org/I32389192"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046875409","display_name":"Andr\u00e9s Azuero","orcid":"https://orcid.org/0000-0001-9883-1424","observed_orcids":["https://orcid.org/0000-0001-9883-1424"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Azuero","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855","https://openalex.org/I32389192"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026681970","display_name":"Maria Pisu","orcid":"https://orcid.org/0000-0001-9329-3268","observed_orcids":["https://orcid.org/0000-0001-9329-3268"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Pisu","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855","https://openalex.org/I32389192"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062188145","display_name":"KI Halilova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"KI Halilova","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855","https://openalex.org/I32389192"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044568194","display_name":"SA Adewakun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Adewakun","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855","https://openalex.org/I32389192"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060373390","display_name":"SK Yagnik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SK Yagnik","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855","https://openalex.org/I32389192"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022700409","display_name":"H-P Goertz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H-P Goertz","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855","https://openalex.org/I32389192"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102873527","display_name":"Gabrielle Betty Rocque","orcid":"https://orcid.org/0000-0003-4188-9785","observed_orcids":["https://orcid.org/0000-0003-4188-9785"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"GB Rocque","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL; Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855","https://openalex.org/I32389192"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"4_Supplement","first_page":"PD7","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.6445000171661377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.6445000171661377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.26510000228881836,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.03020000085234642,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/guideline-concordant-treatment","display_name":"guideline-concordant treatment","score":0.800000011920929},{"id":"https://openalex.org/keywords/nccn-guidelines","display_name":"NCCN guidelines","score":0.9610000252723694},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.7149999737739563},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.9929999709129333},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.9520000219345093},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.9380000233650208},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.843999981880188},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/medicare-reimbursement","display_name":"Medicare reimbursement","score":0.7059999704360962},{"id":"https://openalex.org/keywords/value-based-health-care","display_name":"value-based care","score":0.8119999766349792},{"id":"https://openalex.org/keywords/older-women","display_name":"older women","score":0.6269999742507935},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.5830000042915344},{"id":"https://openalex.org/keywords/quality-of-cancer-care","display_name":"quality of cancer care","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8750292658805847},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.7930942177772522},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7363742589950562},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.718363881111145},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5854296088218689},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.5704180002212524},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.48585888743400574},{"id":"https://openalex.org/C2780724011","wikidata":"https://www.wikidata.org/wiki/Q1295316","display_name":"Emergency department","level":2,"score":0.46635332703590393},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3852696418762207},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.35887205600738525},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3535892963409424},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.08929097652435303},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs17-pd7-01","doi":"https://doi.org/10.1158/1538-7445.sabcs17-pd7-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs17-pd7-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2886940144","https://openalex.org/W2896416611","https://openalex.org/W2794325158","https://openalex.org/W2890352361","https://openalex.org/W3172869754","https://openalex.org/W4281720641","https://openalex.org/W4402759147","https://openalex.org/W2979872375","https://openalex.org/W3113144447","https://openalex.org/W3027302942"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"National":[2],"Comprehensive":[3],"Cancer":[4,91,485,496],"Network":[5],"(NCCN)":[6],"guideline-based":[7],"treatment":[8,39,103,130,152,200,217,231,265,275,286,405,463],"is":[9,56],"increasingly":[10],"recognized":[11],"as":[12,28],"a":[13,61,208,215],"marker":[14],"of":[15,38,64,87,128,150,260,285,309,339,375,396,415,428,460,479],"high":[16],"quality":[17],"care.":[18,34],"Payers":[19],"are":[20],"progressively":[21],"limiting":[22],"reimbursement":[23],"for":[24,71,102,118,201,272,287,333,348,367,421],"non-guideline":[25],"based":[26],"care":[27,49,83,120,137,417,468],"they":[29],"move":[30],"towards":[31],"value-based":[32],"cancer":[33,55,80,129,151,379,474],"However,":[35],"the":[36,85,126,148,187,373,436,480],"impact":[37],"regimen":[40],"concordance":[41],"with":[42,76,212,391,409],"NCCN":[43,96],"guidelines":[44,99],"on":[45,199,464],"cost":[46,465],"and":[47,143,159,167,181,191,218,250,278,412,423,438,466],"health":[48,416,467],"utilization":[50,138,162,418,469],"in":[51,387,399,470],"early":[52,202,376,471],"stage":[53,77,203,246,377,472],"breast":[54,79,204,378,473],"unclear.":[57],"Methods:":[58],"This":[59],"was":[60,100,145,406],"secondary":[62],"analysis":[63],"Medicare":[65,114],"administrative":[66],"claims":[67],"data":[68],"from":[69,125,147,434],"2012-2015":[70],"all":[72,119],"women":[73],"aged":[74],"\u226565":[75],"I-III":[78],"who":[81],"received":[82,207,262],"within":[84],"University":[86],"Alabama":[88],"at":[89,239,318,352],"Birmingham":[90],"Community":[92],"Network.":[93],"Concordance":[94],"to":[95,113,116,235,295,326,360],"Clinical":[97],"Practice":[98],"assessed":[101],"regimens":[104],"including":[105],"hormonal":[106],"medications,":[107],"chemotherapy,":[108],"and/or":[109],"HER2-targeted":[110],"therapy.":[111],"Costs":[112],"(reimbursements":[115],"providers":[117],"received)":[121],"were":[122,174,232,291,315,344],"averaged":[123],"monthly":[124,161,281],"start":[127,149],"until":[131,153],"death":[132,154],"or":[133,155],"available":[134,156],"follow-up.":[135,157],"Health":[136],"(emergency":[139],"department":[140],"[ED]":[141],"visits":[142,311],"hospitalizations)":[144],"identified":[146],"Cost":[158],"adjusted":[160,307],"rates":[163,308,338,414],"per":[164,312,320,328,341,354,362],"thousand":[165,313,342],"observations":[166,314,343],"their":[168],"corresponding":[169],"95%":[170],"confidence":[171],"intervals":[172],"(CI)":[173],"estimated":[175],"using":[176,186],"linear":[177,183],"mixed":[178],"effect":[179],"models":[180],"generalized":[182],"models,":[184],"respectively,":[185],"negative":[188,252],"binomial":[189],"distribution":[190],"log":[192],"link":[193],"function.":[194],"Results:":[195],"Of":[196],"1042":[197],"patients":[198,255,261,290,298,351,380,475],"cancer,":[205,247],"82%":[206],"guideline":[209,229,263,288,296,304,334,349,368,382,397,429,461],"concordant":[210,230,264,289,305,350,383,404,462],"treatment,":[211],"79%":[213],"receiving":[214,220,228,256,381,401],"\u201cpreferred\u201d":[216],"3%":[219],"an":[221,244,392],"\u201cother\u201d":[222],"but":[223],"still":[224],"on-guideline":[225],"treatment.":[226],"Those":[227],"more":[233],"likely":[234],"be":[236,432],"white,":[237],"treated":[238],"large":[240],"volume":[241],"centers,":[242],"have":[243],"earlier":[245],"ER/PR":[248],"positive,":[249],"HER2":[251],"(p<0.05).":[253],"Among":[254],"chemotherapy":[257],"(N=496),":[258],"63%":[259],"(55%":[266],"\u201cpreferred\u201d,":[267],"8%":[268],"\u201cother\u201d).":[269],"After":[270],"adjusting":[271,420],"age,":[273],"race,":[274],"center":[276,424],"volume,":[277],"stage,":[279],"average":[280],"costs":[282,411],"after":[283,419],"initiation":[284],"$1464":[292],"lower":[293,317,347,410,413],"compared":[294,325,359],"discordant":[297,335,369],"(95%":[299,322,330,356,364],"CI":[300,323,331,357,365],"$1135-$1793,":[301],"p<.001).":[302],"For":[303],"patients,":[306],"ED":[310],"41%":[316,346],"51.3":[319],"month":[321,329,355,363],"44.0-59.8)":[324],"77.9":[327],"62.6-96.9)":[332],"patients.":[336,370],"Adjusted":[337],"hospitalizations":[340],"also":[345],"28.2":[353],"23.5-33.8)":[358],"42.7":[361],"32.9-55.5)":[366],"Conclusions:":[371],"Despite":[372],"majority":[374],"care,":[384],"almost":[385],"one":[386],"five":[388],"did":[389],"not,":[390],"even":[393],"higher":[394],"proportion":[395],"discordance":[398],"those":[400],"chemotherapy.":[402],"Guideline":[403],"significantly":[407],"associated":[408],"patient":[422,437],"characteristics.":[425],"The":[426],"appropriateness":[427],"deviation":[430],"should":[431],"examined":[433],"both":[435],"payer":[439],"perspectives.":[440],"Citation":[441],"Format:":[442],"Williams":[443],"CP,":[444],"Azuero":[445],"A,":[446],"Pisu":[447],"M,":[448],"Halilova":[449],"KI,":[450],"Adewakun":[451],"S,":[452],"Yagnik":[453],"SK,":[454],"Goertz":[455],"H-P,":[456],"Rocque":[457],"GB.":[458],"Impact":[459],"[abstract].":[476],"In:":[477],"Proceedings":[478],"2017":[481,487],"San":[482,490],"Antonio":[483],"Breast":[484],"Symposium;":[486],"Dec":[488],"5-9;":[489],"Antonio,":[491],"TX.":[492],"Philadelphia":[493],"(PA):":[494],"AACR;":[495],"Res":[497],"2018;78(4":[498],"Suppl):Abstract":[499],"nr":[500],"PD7-01.":[501]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-03-29T00:00:00"}